{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:44:52Z","timestamp":1787010292388,"version":"build-2736575974"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVES:<\/jats:title>\n                    <jats:p>Children with status asthmaticus refractory to first-line therapies of systemic corticosteroids and inhaled beta-agonists often receive additional treatments. Because there are no national guidelines on the use of asthma therapies in the PICU, we sought to evaluate institutional variability in the use of adjunctive asthma treatments and associations with length of stay (LOS) and PICU use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DESIGN:<\/jats:title>\n                    <jats:p>Multicenter retrospective cohort study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>SETTING:<\/jats:title>\n                    <jats:p>Administrative data from the Pediatric Health Information Systems (PHIS) database.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PATIENTS:<\/jats:title>\n                    <jats:p>All inpatients 2\u201318 years old were admitted to a PHIS hospital between 2013 and 2021 with a diagnostic code for asthma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>INTERVENTIONS:<\/jats:title>\n                    <jats:p>None.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MEASUREMENTS AND MAIN RESULTS:<\/jats:title>\n                    <jats:p>\n                      This study included 213,506 inpatient encounters for asthma, of which 29,026 patient encounters included care in a PICU from 39 institutions. Among these PICU encounters, large variability was seen across institutions in both the number of adjunctive asthma therapies used per encounter (min: 0.6, median: 1.7, max: 2.5,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; 0.01) and types of adjunctive asthma therapies (aminophylline, ipratropium, magnesium, epinephrine, and terbutaline) used. The center-level median hospital LOS ranged from 1 (interquartile range [IQR]: 1, 3) to 4 (3, 6) days. Among all the 213,506 inpatient encounters for asthma, the range of asthma admissions that resulted in PICU admission varied between centers from 5.2% to 47.3%. The average number of adjunctive therapies used per institution was not significantly associated with hospital LOS (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.81) nor the percentage of encounters with PICU admission (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.47).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>Use of adjunctive therapies for status asthmaticus varies widely among large children\u2019s hospitals and was not associated with hospital LOS or the percentage of encounters with PICU admission. Wide variance presents an opportunity for standardizing care with evidence-based guidelines to optimize outcomes and decrease adverse treatment effects and hospital costs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/pcc.0000000000003347","type":"journal-article","created":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T10:04:36Z","timestamp":1692871476000},"page":"37-46","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":24,"title":["Wide Institutional Variability in the Treatment of Pediatric Critical Asthma: A Multicenter Retrospective Study"],"prefix":"10.1097","volume":"25","author":[{"given":"Colin M.","family":"Rogerson","sequence":"first","affiliation":[{"name":"Division of Pediatric Critical Care Medicine, Indiana University School of Medicine, Indianapolis, IN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander H.","family":"Hogan","sequence":"additional","affiliation":[{"name":"Division of Hospital Medicine, Connecticut Children\u2019s Medical Center, Hartford, CT."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Briana","family":"Waldo","sequence":"additional","affiliation":[{"name":"Department of Respiratory Therapy, Rainbow Babies and Children\u2019s Hospital, Cleveland, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin R.","family":"White","sequence":"additional","affiliation":[{"name":"Division of Pediatric Critical Care Medicine, University of Utah, Salt Lake City, UT."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher L","family":"Carroll","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Wolfson Children\u2019s, University of Florida, Jacksonville, FL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven L.","family":"Shein","sequence":"additional","affiliation":[{"name":"Division of Pediatric Critical Care Medicine, Rainbow Babies and Children\u2019s Hospital, Cleveland, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,8,24]]},"reference":[{"key":"R1-20250502","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/PCC.0000000000002956","article-title":"Epidemiology of pediatric critical care admissions in 43 United States children\u2019s hospitals, 2014-2019.","volume":"23","author":"Heneghan","year":"2022","journal-title":"Pediatr Crit Care Med"},{"key":"R2-20250502","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3389\/fped.2019.00246","article-title":"Epidemiology of asthma in children and adults.","volume":"7","author":"Dharmage","year":"2019","journal-title":"Front Pediatr"},{"key":"R4-20250502","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ccc.2012.12.001","article-title":"Pediatric status asthmaticus.","volume":"29","author":"Carroll","year":"2013","journal-title":"Crit Care Clin"},{"key":"R5-20250502","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jpeds.2012.02.041","article-title":"Fatal and near-fatal asthma in children: The critical care perspective.","volume":"161","author":"Newth","year":"2012","journal-title":"J Pediatr"},{"key":"R6-20250502","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jpeds.2005.05.008","article-title":"Regional variation in ICU care for pediatric patients with asthma.","volume":"147","author":"Bratton","year":"2005","journal-title":"J Pediatr"},{"key":"R7-20250502","first-page":"CD012977","article-title":"Interventions for escalation of therapy for acute exacerbations of asthma in children: An overview of Cochrane Reviews.","volume":"8","author":"Craig","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"R8-20250502","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/resp.13085","article-title":"Severe asthma in children.","volume":"22","author":"Bush","year":"2017","journal-title":"Respirology"},{"key":"R9-20250502","doi-asserted-by":"crossref","first-page":"849","DOI":"10.4187\/respcare.05174","article-title":"Adjunct therapies for refractory status asthmaticus in children.","volume":"62","author":"Rehder","year":"2017","journal-title":"Respir Care"},{"key":"R10-20250502","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1542\/hpeds.2017-0088","article-title":"Adjunctive pharmacotherapies in children with asthma exacerbations requiring continuous albuterol therapy: Findings from the Ohio pediatric asthma repository.","volume":"8","author":"Shein","year":"2018","journal-title":"Hosp Pediatr"},{"key":"R11-20250502","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1136\/bmj.325.7370.961","article-title":"Unwarranted variations in healthcare delivery: Implications for academic medical centres.","volume":"325","author":"Wennberg","year":"2002","journal-title":"BMJ"},{"key":"R12-20250502","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1080\/02770903.2020.1741612","article-title":"Implementing pediatric inpatient asthma pathways.","volume":"58","author":"Gupta","year":"2021","journal-title":"J Asthma"},{"key":"R13-20250502","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1080\/02770903.2017.1316392","article-title":"Rising utilization of inpatient pediatric asthma pathways.","volume":"55","author":"Kaiser","year":"2018","journal-title":"J Asthma"},{"key":"R14-20250502","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.4187\/respcare.06447","article-title":"Implementing a respiratory therapist-driven continuous albuterol weaning protocol in the pediatric ICU.","volume":"64","author":"Maue","year":"2019","journal-title":"Respir Care"},{"key":"R15-20250502","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1002\/ppul.24821","article-title":"Terbutaline and aminophylline as second-line therapies for status asthmaticus in the pediatric intensive care unit.","volume":"55","author":"Stulce","year":"2020","journal-title":"Pediatr Pulmonol"},{"key":"R16-20250502","doi-asserted-by":"crossref","first-page":"283","DOI":"10.4103\/1817-1737.191874","article-title":"Ketamine versus aminophylline for acute asthma in children: A randomized, controlled trial.","volume":"11","author":"Tiwari","year":"2016","journal-title":"Ann Thorac Med"},{"key":"R17-20250502","first-page":"CD010256","article-title":"Intravenous beta(2)-agonists versus intravenous aminophylline for acute asthma.","volume":"12","author":"Travers","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"R18-20250502","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1080\/02770903.2019.1590588","article-title":"US racial\/ethnic disparities in childhood asthma emergent health care use: National Health Interview Survey, 2013-2015.","volume":"57","author":"Urquhart","year":"2020","journal-title":"J Asthma"},{"key":"R19-20250502","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.acap.2016.11.011","article-title":"Pediatric asthma health disparities: Race, hardship, housing, and asthma in a national survey.","volume":"17","author":"Hughes","year":"2017","journal-title":"Acad Pediatr"},{"key":"R20-20250502","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3109\/02770903.2014.984843","article-title":"Factors associated with length of stay for pediatric asthma hospitalizations.","volume":"52","author":"Shanley","year":"2015","journal-title":"J Asthma"},{"key":"R21-20250502","doi-asserted-by":"crossref","first-page":"E13","DOI":"10.1542\/peds.101.4.e13","article-title":"Comparison of length of stay for asthma by hospital type.","volume":"101","author":"Samuels","year":"1998","journal-title":"Pediatrics"},{"key":"R23-20250502","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/jhm.2624","article-title":"Epidemiology of pediatric hospitalizations at general hospitals and freestanding children\u2019s hospitals in the United States.","volume":"11","author":"Leyenaar","year":"2016","journal-title":"J Hosp Med"},{"issue":"5 Suppl","key":"R24-20250502","first-page":"S94","article-title":"Guidelines for the diagnosis and management of asthma-summary report 2007.","volume":"120","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"R25-20250502","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00431-019-03502-9","article-title":"Current practices in children with severe acute asthma across European PICUs: An ESPNIC survey.","volume":"179","author":"Boeschoten","year":"2020","journal-title":"Eur J Pediatr"},{"key":"R26-20250502","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1080\/14712598.2020.1751115","article-title":"Pediatric use of omalizumab for allergic asthma.","volume":"20","author":"Pajno","year":"2020","journal-title":"Expert Opin Biol Ther"},{"key":"R27-20250502","doi-asserted-by":"crossref","first-page":"e225","DOI":"10.1097\/pq9.0000000000000225","article-title":"Continuous albuterol in pediatric acute care: Study demonstrates safety outside the intensive care unit.","volume":"4","author":"Messer","year":"2019","journal-title":"Pediatr Qual Saf"},{"key":"R28-20250502","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1080\/02770903.2022.2047717","article-title":"Cost analysis of hospitals performing continuous albuterol in non-intensive care settings.","volume":"60","author":"Andoh","year":"2022","journal-title":"J Asthma"},{"key":"R29-20250502","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMc2029240","article-title":"Racial bias in pulse oximetry measurement.","volume":"383","author":"Sjoding","year":"2020","journal-title":"N Engl J Med"},{"key":"R30-20250502","doi-asserted-by":"crossref","first-page":"e224584","DOI":"10.1001\/jamanetworkopen.2022.4584","article-title":"Association of race with pulse oximetry accuracy in hospitalized children.","volume":"5","author":"Andrist","year":"2022","journal-title":"JAMA Netw Open"},{"key":"R31-20250502","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/PCC.0000000000003208","article-title":"Pulse oximetry and arterial saturation difference in pediatric COVID-19 patients: Retrospective analysis by race.","volume":"24","author":"Savorgnan","year":"2023","journal-title":"Pediatr Crit Care Med"},{"key":"R32-20250502","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/PCC.0000000000003229","article-title":"Discrimination by design: Is it time to recalibrate interpretation of pulse oximetry?","volume":"24","author":"Barreto","year":"2023","journal-title":"Pediatr Crit Care"},{"key":"R33-20250502","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.jaip.2021.10.065","article-title":"Geospatial analysis of social determinants of health identifies neighborhood hot spots associated with pediatric intensive care use for life-threatening asthma.","volume":"10","author":"Grunwell","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R34-20250502","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1007\/s11524-021-00582-7","article-title":"Multi-level socioenvironmental contributors to childhood asthma in New York City: A cluster analysis.","volume":"98","author":"Khan","year":"2021","journal-title":"J Urban Health"},{"key":"R35-20250502","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1177\/08850666221082540","article-title":"Dexamethasone for pediatric critical asthma: A multicenter descriptive study.","volume":"37","author":"Sellers","year":"2022","journal-title":"J Intensive Care Med"},{"key":"R36-20250502","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1177\/08850666211026550","article-title":"Heliox for pediatric critical asthma: A multicenter, retrospective, registry-based descriptive study.","volume":"37","author":"Lew","year":"2022","journal-title":"J Intensive Care Med"}],"container-title":["Pediatric Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PCC.0000000000003347","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T13:11:05Z","timestamp":1746191465000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PCC.0000000000003347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,24]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/pcc.0000000000003347","relation":{},"ISSN":["1529-7535"],"issn-type":[{"value":"1529-7535","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,24]]}}}